Morgan Stanley Private Equity Asia Overview

  • Investor Type
  • PE/​Buyout

  • Status
  • Active

  • Professionals
  • 23

Professionals

  • Investments
  • 139

  • Portfolio
  • 51

  • Exits
  • 86

Exits

Morgan Stanley Private Equity Asia General Information

Company Description

Founded in 1993, Morgan Stanley Private Equity Asia is a private equity arm of Morgan Stanley Investment Management firm based in Hong Kong, Hong Kong. The firm seeks to invest in companies operating in the consumer product, industrial products, financial services, healthcare, telecom, and technology sectors.

Business Details

Year Founded
1993
Investor Status
Actively Seeking New Investments
Primary Investor Type
PE/Buyout
Other Investor Types
Growth/Expansion
Corporate Office
  • International Commerce Centre, 1 Austin Road
  • West Kowloon
  • Hong Kong
  • Hong Kong

Morgan Stanley Private Equity Asia Investments (139)

Morgan Stanley Private Equity Asia’s most recent investment was a with Gujarat Pathology Laboratory & Diagnostic Center. The deal was made on 16-Apr-2025.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Gujarat Pathology Laboratory & Diagnostic Center 16-Apr-2025 Laboratory Services (Healthcare) Generating Revenue
Dr Agarwals Healthcare 28-Jan-2025 Hospitals/Inpatient Services Profitable
Bajaj Housing Finance 05-Sep-2024 Consumer Finance Profitable
DEE Piping Systems 18-Jun-2024 Industrial Supplies and Parts Profitable
Mphasis 10-Jun-2024 Secondary Transaction - Open Market IT Consulting and Outsourcing Profitable
You’re viewing 5 of 139 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Morgan Stanley Private Equity Asia Exits (86)

Morgan Stanley Private Equity Asia has made a total of 86 exits. Its latest exit was from Monalisa for on 08-Nov-2024. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size
Monalisa 08-Nov-2024
DEE Piping Systems 26-Jun-2024
Kogta Financial 26-Jun-2024
Jeonju Paper 09-May-2024
Thai Credit Retail Bank 09-Feb-2024 IPO
You’re viewing 5 of 86 exits. Get the full list »

Morgan Stanley Private Equity Asia Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Morgan Stanley Private Equity Asia‘s full profile, request access.

Request a free trial

Morgan Stanley Private Equity Asia Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Morgan Stanley Private Equity Asia FAQs

  • What is Morgan Stanley Private Equity Asia?

    Founded in 1993, Morgan Stanley Private Equity Asia is a private equity arm of Morgan Stanley Investment Management firm based in Hong Kong, Hong Kong.

  • When was Morgan Stanley Private Equity Asia founded?

    Morgan Stanley Private Equity Asia was founded in 1993.

  • Where is Morgan Stanley Private Equity Asia headquartered?

    Morgan Stanley Private Equity Asia is headquartered in Hong Kong, Hong Kong.

  • What is Morgan Stanley Private Equity Asia's total asset value?

    Morgan Stanley Private Equity Asia has around in total assets under management.

  • How many investments has Morgan Stanley Private Equity Asia made?

    Morgan Stanley Private Equity Asia has made 139 investments.

  • What has Morgan Stanley Private Equity Asia invested in?

    Morgan Stanley Private Equity Asia has made numerous investments in companies like Gujarat Pathology Laboratory & Diagnostic Center, Dr Agarwals Healthcare, and Bajaj Housing Finance within the Laboratory Services (Healthcare), Hospitals/Inpatient Services, and Consumer Finance industries.

  • What has Morgan Stanley Private Equity Asia invested in recently?

    Morgan Stanley Private Equity Asia's latest investment was on 16-Apr-2025 in Gujarat Pathology Laboratory & Diagnostic Center, a company within the Laboratory Services (Healthcare) industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »